Clinical Trials Directory

Trials / Completed

CompletedNCT00928655

Continuous Positive Airway Pressure and Acetazolamide to Treat Sleep Apnea Syndrome Patients at Altitude

Continuous Positive Airway Pressure (CPAP) and Acetazolamide for Treatment of Patients With the Obstructive Sleep Apnea Syndrome at Altitude

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
51 (actual)
Sponsor
University of Zurich · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to investigate the effect of nasal continuous positive airway pressure in combination with acetazolamide as a treatment for sleep related breathing disturbances in patients with the obstructive sleep apnea syndrome living at low altitude during a sojourn at moderate altitude.

Conditions

Interventions

TypeNameDescription
DRUGacetazolamideacetazolamide 250mg 1/0/2
PROCEDUREnocturnal continuous positive airway pressurecontinuous positive airway pressure
DRUGplaceboplacebo capsules

Timeline

Start date
2009-06-01
Primary completion
2009-11-01
Completion
2009-11-01
First posted
2009-06-26
Last updated
2014-05-20

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT00928655. Inclusion in this directory is not an endorsement.